You're using an outdated browser. This website will not display correctly and some features will not work.
Learn more about the browsers we support for a faster and safer online experience.

Midwifery Act, 1991
Loi de 1991 sur les sages-femmes

ONTARIO REGULATION 884/93

DESIGNATED DRUGS

Consolidation Period: From January 22, 2010 to the e-Laws currency date.

Last amendment: O. Reg. 13/10.

This Regulation is made in English only.

1. For the purposes of paragraph 5 of section 4 of the Act, the following substances are designated as substances that a member may administer by injection on the member’s own responsibility:

Ampicillin — for the purpose of preventing neonatal group B streptococcal disease

Bupivacaine — for the purpose of local anaesthesia for episiotomy or the repair of tears

Carbetocin

Carboprost tromethamine

Cefazolin — for the purpose of preventing neonatal group B streptococcal disease

Chloroprocaine — for the purpose of local anaesthesia for episiotomy or the repair of tears

Clindamycin — for the purpose of preventing neonatal group B streptococcal disease

Dimenhydrinate

Diphenhydramine hydrochloride

Epinephrine hydrochloride

Ergonovine maleate

Erythromycin — for the purpose of preventing neonatal group B streptococcal disease

Hepatitis B immune globulin

Hepatitis B vaccine

Intravenous fluids

Lidocaine hydrochloride with or without epinephrine — for the purpose of local anaesthesia for episiotomy or the repair of tears

Measles-mumps-rubella virus vaccine

Oxytocin

Penicillin G — for the purpose of preventing neonatal group B streptococcal disease

Phytonadione

RhD immune globulin

Varicella Zoster immune globulin

O. Reg. 13/10, s. 1.

2. For the purposes of paragraph 5 of section 4 of the Act, the following substances are designated as substances that a member may administer by inhalation on the member’s own responsibility:

Nitrous oxide

Therapeutic oxygen

O. Reg. 884/93, s. 2.

3. For the purposes of paragraph 6 of section 4 of the Act, the following drugs are designated as drugs that a member may prescribe on the member’s own responsibility:

Amoxicillin-clavulanic acid — for the purpose of treating mastitis

Cephalexin — for the purpose of treating mastitis

Ciprofloxacin (oral)

Clotrimazole

Clindamycin (oral)

Cloxacillin (oral)

Diclofenac (oral)

Domperidone — for the purpose of promoting lactation

Doxylamine succinate-pyridoxine hydrochloride

Ergonovine maleate (oral)

Erythromycin ophthalmic ointment

Folic acid (oral; greater than 1mg/dose)

Hepatitis B immune globulin

Hepatitis B vaccine

Hydrocortisone anorectal therapy compound

Metronidazole (oral)

Miconazole

Misoprostol — for the purpose of preventing postpartum hemorrhage

Mupirocin-betamethasone valerate-miconazole (topical)

Naproxen (oral)

Nitrofurantoin — for the purpose of treating urinary tract infections

Nystatin

Phytonadione

RhD immune globulin

Sulfamethoxazole-trimethoprim (oral)

Trimethoprim — for the purpose of treating urinary tract infections

O. Reg. 13/10, s. 2.

4. (1) In the course of engaging in the practice of midwifery, a member may use any drug on the order of a member of the College of Physicians and Surgeons of Ontario. O. Reg. 13/10, s. 3.

(2) For the purposes of paragraph 5 of section 4 of the Act, a member may administer any substance by injection or inhalation on the order of a member of the College of Physicians and Surgeons of Ontario. O. Reg. 13/10, s. 3.

5. A member may administer, prescribe or order any drug or substance that may lawfully be purchased or acquired without a prescription. O. Reg. 884/93, s. 5.

6. Omitted (provides for coming into force of provisions of this Regulation). O. Reg. 884/93, s. 6.